Organon (NYSE: OGN) reported Q4 EPS of $1.37, $0.10 better than the analyst estimate of $1.27. Revenue for the quarter came in at $1.6 billion versus the consensus estimate of $1.57 billion.

GUIDANCE:

Organon sees FY2022 revenue of $6.1-6.4 billion, versus the consensus of $6.33 billion.

For earnings history and earnings-related data on Organon (OGN) click here.